These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
561 related items for PubMed ID: 2105329
1. Differential regulation of luteinizing hormone, follicle-stimulating hormone, and free alpha-subunit secretion from the gonadotrope by gonadotropin-releasing hormone (GnRH): evidence from the use of two GnRH antagonists. Hall JE, Whitcomb RW, Rivier JE, Vale WW, Crowley WF. J Clin Endocrinol Metab; 1990 Feb; 70(2):328-35. PubMed ID: 2105329 [Abstract] [Full Text] [Related]
2. Evidence of differential control of FSH and LH secretion by gonadotropin-releasing hormone (GnRH) from the use of a GnRH antagonist. Hall JE, Brodie TD, Badger TM, Rivier J, Vale W, Conn PM, Schoenfeld D, Crowley WF. J Clin Endocrinol Metab; 1988 Sep; 67(3):524-31. PubMed ID: 3137243 [Abstract] [Full Text] [Related]
3. Persistence of concordant luteinizing hormone (LH), testosterone, and alpha-subunit pulses after LH-releasing hormone antagonist administration in normal men. Pavlou SN, Veldhuis JD, Lindner J, Souza KH, Urban RJ, Rivier JE, Vale WW, Stallard DJ. J Clin Endocrinol Metab; 1990 May; 70(5):1472-8. PubMed ID: 2110578 [Abstract] [Full Text] [Related]
4. Effect of administration of a gonadotropin-releasing hormone (GnRH) antagonist (Nal-Glu) during the periovulatory period: the luteinizing hormone surge requires secretion of GnRH. Dubourdieu S, Charbonnel B, D'Acremont MF, Carreau S, Spitz IM, Bouchard P. J Clin Endocrinol Metab; 1994 Feb; 78(2):343-7. PubMed ID: 8106622 [Abstract] [Full Text] [Related]
5. Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix). Andreyko JL, Monroe SE, Marshall LA, Fluker MR, Nerenberg CA, Jaffe RB. J Clin Endocrinol Metab; 1992 Feb; 74(2):399-405. PubMed ID: 1370507 [Abstract] [Full Text] [Related]
6. Variable tolerance of the developing follicle and corpus luteum to gonadotropin-releasing hormone antagonist-induced gonadotropin withdrawal in the human. Hall JE, Bhatta N, Adams JM, Rivier JE, Vale WW, Crowley WF. J Clin Endocrinol Metab; 1991 May; 72(5):993-1000. PubMed ID: 1902489 [Abstract] [Full Text] [Related]
7. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition. Kettel LM, Roseff SJ, Chiu TC, Bangah ML, Vale W, Rivier J, Burger HG, Yen SS. J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486 [Abstract] [Full Text] [Related]
8. Effects of gonadotrophin releasing hormone antagonist and agonist on the pulsatile release of gonadotrophins and alpha-subunit in postmenopausal women. Couzinet B, Lahlou N, Thomas G, Thalabard JC, Bouchard P, Roger M, Schaison G. Clin Endocrinol (Oxf); 1991 Jun; 34(6):477-83. PubMed ID: 1716186 [Abstract] [Full Text] [Related]
10. The importance of luteinizing hormone in the control of inhibin and progesterone secretion by the human corpus luteum. McLachlan RI, Cohen NL, Vale WW, Rivier JE, Burger HG, Bremner WJ, Soules MR. J Clin Endocrinol Metab; 1989 Jun; 68(6):1078-85. PubMed ID: 2498381 [Abstract] [Full Text] [Related]
11. Regulation of pituitary glycoprotein alpha-subunit secretion after administration of a luteinizing hormone-releasing hormone antagonist in normal men. Lindner J, Rivier JE, Vale WW, Pavlou SN. J Clin Endocrinol Metab; 1990 Apr; 70(4):1219-24. PubMed ID: 1690747 [Abstract] [Full Text] [Related]
12. Gonadotropin-releasing hormone pulse generator activity during pubertal transition in girls: pulsatile and diurnal patterns of circulating gonadotropins. Apter D, Bützow TL, Laughlin GA, Yen SS. J Clin Endocrinol Metab; 1993 Apr; 76(4):940-9. PubMed ID: 8473410 [Abstract] [Full Text] [Related]
13. Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist. Daneshdoost L, Pavlou SN, Molitch ME, Gennarelli TA, Savino PJ, Sergott RC, Bosley TM, River JE, Vale WW, Snyder PJ. J Clin Endocrinol Metab; 1990 Jul; 71(1):92-7. PubMed ID: 2115048 [Abstract] [Full Text] [Related]
14. Gonadotropin-releasing hormone-dependent regulation of gonadotropin subunit messenger ribonucleic acid levels in the rat. Wierman ME, Rivier JE, Wang C. Endocrinology; 1989 Jan; 124(1):272-8. PubMed ID: 2491805 [Abstract] [Full Text] [Related]
16. Comparative effects of two different delivery systems on gonadotropin-releasing hormone (GnRH) antagonist-induced suppression of gonadotropins and testosterone in man. Salameh W, Bhasin S, Steiner BS, McAdams LA, Peterson M, Rivier JE, Vale WW, Swerdloff RS. J Androl; 1994 Jan; 15(1):22-8. PubMed ID: 8188535 [Abstract] [Full Text] [Related]